Wellcome Trust | Evaluate

October 24, 2017

Interview – Syncona’s uncompromising message to the European markets

Interview – Arix ventures to build better returns

November 24, 2016

Kymab joins the $100m club

May 31, 2016

US approval for Blue Earth’s prostate cancer tracer Axumin

December 15, 2015

Interview – Leucid Bio swings for the fences in CAR-T

September 02, 2015

Crisp financing and partnering in gene editing space

January 29, 2015

CRISPR steps closer to centre stage as AstraZeneca piles in

January 23, 2015

Interview – UK CAR-T player enters in stealth mode

May 16, 2014

Interview – Kymab's fully human mice yield $40m

March 18, 2014

EP Vantage interview – Blue Earth Diagnostics “super focused” on GE’s PET tracer

January 31, 2014

Syncona has the finishing line in sight with $20m gene therapy investment

Load More